These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2169655

  • 1. Lp(a): an interloper into the fibrinolytic system?
    Miles LA, Plow EF.
    Thromb Haemost; 1990 Jun 28; 63(3):331-5. PubMed ID: 2169655
    [No Abstract] [Full Text] [Related]

  • 2. A potential basis for the thrombotic risks associated with lipoprotein(a).
    Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF.
    Nature; 1989 May 25; 339(6222):301-3. PubMed ID: 2542796
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR, Ho J, Taylor FB, Boffa MB, Jia Z, Koschinsky ML.
    Biochemistry; 2005 Jan 18; 44(2):555-64. PubMed ID: 15641780
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.
    Scanu AM.
    Arch Pathol Lab Med; 1988 Oct 18; 112(10):1045-7. PubMed ID: 2972266
    [Abstract] [Full Text] [Related]

  • 12. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X, Huby T, Wickins J, Chapman J, Thillet J.
    Biochemistry; 1998 May 19; 37(20):7213-23. PubMed ID: 9585533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT.
    Exp Cell Res; 1996 May 01; 224(2):344-53. PubMed ID: 8612711
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D.
    Prog Hemost Thromb; 1986 May 01; 8():1-18. PubMed ID: 3104986
    [No Abstract] [Full Text] [Related]

  • 20. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M.
    Biochemistry; 1998 Nov 24; 37(47):16494-505. PubMed ID: 9843416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.